Joseph C. Ventura - 15 Dec 2025 Form 4 Insider Report for HUMANA INC (HUM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Dec 2025, 10:19:37 UTC
Prior SEC filing
25 Feb 2025
Next SEC filing
26 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Joseph C. Ventura

Key filing fact

Joseph C. Ventura filed Form 4 for HUMANA INC (HUM) on 17 Dec 2025.

Key facts

  • This page summarizes Joseph C. Ventura's Form 4 filing for HUMANA INC (HUM).
  • 5 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 17 Dec 2025, 10:19.

Change

  • Previous filing in this sequence was filed on 25 Feb 2025.
  • Current net transaction value: -$296,360.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001768291 Primary reporting owner

Ventura Joseph C

Relationship
Chief Legal Officer
Address
HUMANA INC., 500 W MAIN STREET, LOUISVILLE
Signature
Joseph C. Ventura
Signature date
17 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM transaction

Humana Common

Options Exercise

Transaction value
$0
Shares
+2,046
Change %
+13%
Price
$0.000000
Shares after
17,267
Date
15 Dec 2025
Ownership
Direct
HUM transaction

Humana Common

Tax liability

Transaction value
$252,055
Shares
-933
Change %
-5.4%
Price
$270.16
Shares after
16,334
Date
15 Dec 2025
Ownership
Direct
Footnotes
F10
HUM transaction

Humana Common

Options Exercise

Transaction value
$0
Shares
+360
Change %
+2.2%
Price
$0.000000
Shares after
16,694
Date
15 Dec 2025
Ownership
Direct
HUM transaction

Humana Common

Tax liability

Transaction value
$44,305
Shares
-164
Change %
-0.98%
Price
$270.16
Shares after
16,530
Date
15 Dec 2025
Ownership
Direct
Footnotes
F9, F10
HUM holding

Humana Common

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
290
Date
15 Dec 2025
Ownership
See Footnote
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-360
Change %
-100%
Price
$0.000000
Shares after
0
Date
15 Dec 2025
Ownership
Direct
Underlying class
Humana Common
Underlying amount
360
Exercise price
Footnotes
F7, F8
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,656
Date
15 Dec 2025
Ownership
Direct
Underlying class
Humana Common
Underlying amount
4,656
Exercise price
$350.79
Footnotes
F2
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,598
Date
15 Dec 2025
Ownership
Direct
Underlying class
Humana Common
Underlying amount
4,598
Exercise price
$376.61
Footnotes
F3
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,932
Date
15 Dec 2025
Ownership
Direct
Underlying class
Humana Common
Underlying amount
3,932
Exercise price
$425.06
Footnotes
F4
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,162
Date
15 Dec 2025
Ownership
Direct
Underlying class
Humana Common
Underlying amount
4,162
Exercise price
$510.24
Footnotes
F5
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,572
Date
15 Dec 2025
Ownership
Direct
Underlying class
Humana Common
Underlying amount
6,572
Exercise price
$367.21
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Shares held for the benefit of reporting person as of November 30, 2025 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).

Footnote F2

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

Footnote F3

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

Footnote F4

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.

Footnote F5

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.

Footnote F6

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Footnote F7

Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

Footnote F8

Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Footnote F9

Includes 6,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Footnote F10

Shares disposed of represent payment for tax liability on shares vesting vested on 12/15/25. No value was received in return.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .